Novotech Health Holdings Pte Ltd: Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific

SYDNEY, AU, Feb 10, 2023 - (ACN Newswire) - Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phase 1 trial activity including current metrics on fast growth

Related Keywords

China ,Australia ,Japan ,United States ,India ,Sydney ,New South Wales ,South Korea ,Novotech ,Asia Pacific ,David James ,Contract Research Organization ,Novotech Health Holdings Pte Ltd ,Site Partnership ,Global Clinical Trial Landscape ,Asia Pacific Cell ,Gene Therapy Clinical Trials Excellence ,Novotech Health Holdings Pte ,Marcel Torney ,Health ,Oldings ,Lobal ,Report ,Obust ,Hase ,Trial ,Growth ,Cross ,Sia ,Acific ,